In this randomized, double-blind, placebo-controlled trial, almost 400 people with severe coronary artery calcification received either vitamin K2 and vitamin D3 or a placebo every day for two years. Participants receiving the vitamins were given 720 micrograms of vitamin K2 in its MK-7 form, together with 25 micrograms (1,000 IU) of vitamin D3. At the end of the study, progression of coronary artery calcification was approximately 21 percent lower in the vitamin group than among those receiving placebo.
Coronary artery calcification reflects the buildup of calcium in plaques within the arteries supplying the heart and is an established marker of cardiovascular disease risk. Importantly, the researchers found no evidence that slowing calcification resulted in an increase in non-calcified plaque. The study did not, however, establish that taking K2 and D3 prevents heart attacks, strokes, or cardiovascular deaths. Larger and longer trials will be required to determine whether the reduction in calcification ultimately translates into fewer such events.
The findings nevertheless provide impressive evidence of the potential cardiovascular effects of these micronutrients. They also illustrate an important principle: vitamins do not operate independently of one another in the human body. Vitamin D has an important role in calcium metabolism, while vitamin K helps activate proteins involved in directing calcium towards bones and away from inappropriate deposition in soft tissues. Rather than viewing individual vitamins in isolation, researchers should be examining how specific combinations of essential micronutrients can work together synergistically in maintaining cardiovascular health.
To check out Dr. Rath’s Cellular Health Recommendations for healthy arteries, see this page on our website.
Luxembourg Introduces New Maximum Permitted Levels for Vitamins and Minerals in Supplements
October 9, 2026Arginine & Vitamin C Linked to Greater Reduction in Fatigue During Pulmonary Rehabilitation in Advanced COPD
October 9, 2026Vitamins K2 and D3 Found to Slow Coronary Calcification
News
A two-year randomized controlled trial has found that daily supplementation with vitamin K2 and vitamin D3 was associated with a 21 percent reduction in the progression of coronary artery calcification compared with placebo.
[Source: nutraceuticalbusinessreview.com]
[Image source: unsplash.com]
Comment
In this randomized, double-blind, placebo-controlled trial, almost 400 people with severe coronary artery calcification received either vitamin K2 and vitamin D3 or a placebo every day for two years. Participants receiving the vitamins were given 720 micrograms of vitamin K2 in its MK-7 form, together with 25 micrograms (1,000 IU) of vitamin D3. At the end of the study, progression of coronary artery calcification was approximately 21 percent lower in the vitamin group than among those receiving placebo.
Coronary artery calcification reflects the buildup of calcium in plaques within the arteries supplying the heart and is an established marker of cardiovascular disease risk. Importantly, the researchers found no evidence that slowing calcification resulted in an increase in non-calcified plaque. The study did not, however, establish that taking K2 and D3 prevents heart attacks, strokes, or cardiovascular deaths. Larger and longer trials will be required to determine whether the reduction in calcification ultimately translates into fewer such events.
The findings nevertheless provide impressive evidence of the potential cardiovascular effects of these micronutrients. They also illustrate an important principle: vitamins do not operate independently of one another in the human body. Vitamin D has an important role in calcium metabolism, while vitamin K helps activate proteins involved in directing calcium towards bones and away from inappropriate deposition in soft tissues. Rather than viewing individual vitamins in isolation, researchers should be examining how specific combinations of essential micronutrients can work together synergistically in maintaining cardiovascular health.
To check out Dr. Rath’s Cellular Health Recommendations for healthy arteries, see this page on our website.
Dr. Rath Health Foundation
Related posts
Common Pesticide Linked to 2.5 Times the Risk of Parkinson’s Disease
Read more